| Working Groups |  Lingor |
| Subproject | None |
| Open Access |  Yes |
| Publication Type | Randomized Controlled Trial |
| Peer Reviewed | Yes |
| PMID |  38416402 |
| DOI |  10.1007/s40263-024-01070-7 |
| Publication Year | 2024 |
| Title | SAFE-ROCK: A Phase I Trial of an Oral Application of the ROCK Inhibitor Fasudil to Assess Bioavailability, Safety, and Tolerability in Healthy Participants. |
| Journal | CNS drugs |
| ISSN | 1172-7047 |
| ESSN | 1179-1934 |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/?term=38416402%5Buid%5D |
| Pages | 291-302 |
| Issue | 4 |
| Volume | 38 |
| Journal Abbreviation | CNS Drugs |
| Authors | Wolff AW, Peine J, Höfler J, Zurek G, Hemker C, Lingor P |
| First Author | Wolff AW |
| Last Author | Lingor P |
